Arkolith/Insider Trading/MNPR/Form 4

Robinson Chandler

Chief Executive Officer, DirectorMonopar Therapeutics (MNPR) · full profile →Form 4 · filed Apr 2, 2026
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 31, 2026Option exercise(M)7K——92K
Mar 31, 2026Tax withholding(F)2K$54.79$108K90K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Mar 31, 2026Option exercise(M)7K—$0106K

Transaction Codes

M
Option exercise / conversion
F
Shares withheld for taxes

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-26-011079) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML